MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species
Scientific Reports · 2024
DOI: 10.1038/s41598-024-72031-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Elisabeth Roider und 24 weiteren Autor:innen. Beteiligte Einrichtung: Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, USA. Elisabeth.Roider@u…. Hauptthemen laut MEDLINE: Microphthalmia-Associated Transcription Factor, Reactive Oxygen Species, Melanoma, Zebrafish. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Development and Innovation Office, NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte function, development and plays a significant role in melanoma pathogenesis. MITF genomic amplification promotes melanoma development, and it can facilitate resistance to multiple therapies. Here, we show that MITF regulates a global antioxidant program that increases survival of melanoma cell lines by protecting the cells from reactive oxygen species (ROS)-induced damage. In addition, this redox program is correlated with MITF expression in human melanoma cell lines and patient-derived melanoma samples. Using a zebrafish melanoma model, we show that MITF decreases ROS-mediated DNA damage in vivo. Some of the MITF target genes involved, such as IDH1 and NNT , are regulated through direct MITF binding to canonical enhancer box (E-BOX) sequences proximal to their promoters. Utilizing functional experiments, we demonstrate the role of MITF and its target genes in reducing cytosolic and mitochondrial ROS. Collectively, our data identify MITF as a significant driver of the cellular antioxidant state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, USA. Elisabeth.Roider@usb.ch.
- Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA. Elisabeth.Roider@usb.ch.
- Department of Dermatology, University Hospital of Basel, Basel, Switzerland. Elisabeth.Roider@usb.ch.
- HCEMM-SU Translational Dermatology Research Group, Semmelweis University, Budapest, Hungary.
- Department of Physiology, Semmelweis University, Budapest, Hungary.
- Department of Dermatology, Venereology, and Dermatooncology, Semmelweis University, Budapest, Hungary.
Förderung
- Development and Innovation Office
- NCATS NIH HHS
- NCI NIH HHS
- KIM NKFIA
- NIH HHS
- Melanoma Research Alliance
- NIAMS NIH HHS
- KIM
Zitieren
APA
Roider, E., Lakatos, A. I. T., McConnell, A. M., Wang, P., Mueller, A., Kawakami, A., Tsoi, J., Szabolcs, B. L., Ascsillán, A. A., Suita, Y., Igras, V., Lo, J. A., Hsiao, J. J., Lapides, R., Pál, D. M. P., Lengyel, A. S., Navarini, A., Okazaki, A., Iliopoulos, O., …, & Fisher, D. E. (2024). MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species. Scientific Reports. https://doi.org/10.1038/s41598-024-72031-9
Vancouver
Roider E, Lakatos AIT, McConnell AM, Wang P, Mueller A, Kawakami A, et al. MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species. Scientific Reports. 2024. doi:10.1038/s41598-024-72031-9
BibTeX
@article{Roider2024,
author = {Roider, Elisabeth and Lakatos, Alexandra I T and McConnell, Alicia M and Wang, Poguang and Mueller, Alina and Kawakami, Akinori and Tsoi, Jennifer and Szabolcs, Botond L and Ascsillán, Anna A and Suita, Yusuke and Igras, Vivien and Lo, Jennifer A and Hsiao, Jennifer J and Lapides, Rebecca and Pál, Dorottya M P and Lengyel, Anna S and Navarini, Alexander and Okazaki, Arimichi and Iliopoulos, Othon and Németh, István and Graeber, Thomas G and Zon, Leonard and Giese, Roger W and Kemeny, Lajos V and Fisher, David E},
title = {MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-72031-9}
}
EUVIMED